massmed: New England Journal of Medicine: Table of Contents Table of Contents for New England Journal of Medicine. List of articles from both the latest and ahead of print issues.
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19on 25/02/2021 at 10:01 am
New England Journal of Medicine, Ahead of Print. <br/>
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumoniaby Ivan O. Rosas on 25/02/2021 at 10:00 am
New England Journal of Medicine, Ahead of Print. <br/>
- Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soupby Eric J. Rubin on 25/02/2021 at 10:00 am
New England Journal of Medicine, Ahead of Print. <br/>
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Settingby Noa Dagan on 24/02/2021 at 10:02 am
New England Journal of Medicine, Ahead of Print. <br/>
- Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trialby Rianne van Rijn on 24/02/2021 at 10:01 am
New England Journal of Medicine, Ahead of Print. <br/>
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatmenton 24/02/2021 at 10:01 am
New England Journal of Medicine, Volume 384, Issue 8, February 2021. <br/>
- Risdiplam in Type 1 Spinal Muscular Atrophyby Giovanni Baranello on 24/02/2021 at 10:01 am
New England Journal of Medicine, Ahead of Print. <br/>
- β-Thalassemiasby Ali T. Taher on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, Page 727-743, February 2021. <br/>
- Case 6-2021: A 65-Year-Old Man with Eye Pain and Decreased Visionby Marc A. Bouffard on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, Page 745-753, February 2021. <br/>
- Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophreniaby Stephen K. Brannan on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, Page 717-726, February 2021. <br/>
- Colchicine in Patients with Chronic Coronary Diseaseon 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, Page 776-779, February 2021. <br/>
- Audio Interview: The Real-World Effectiveness of Covid-19 Vaccinationby Eric J. Rubin on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, February 2021. <br/>
- Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortalityby David J.A. Jenkins on 24/02/2021 at 10:00 am
New England Journal of Medicine, Ahead of Print. <br/>
- A Large Abdominal Massby Shu Hui Neo on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, February 2021. <br/>
- STING-Induced Inflammation — A Novel Therapeutic Target in ALS?by Philip Van Damme on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, Page 765-767, February 2021. <br/>
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myelomaby Nikhil C. Munshi on 24/02/2021 at 10:00 am
New England Journal of Medicine, Volume 384, Issue 8, Page 705-716, February 2021. <br/>
- Warming Up to Cold Perfusionby Winfred W. Williams on 24/02/2021 at 10:00 am
New England Journal of Medicine, Ahead of Print. <br/>
- Telemedicine and Medical Licensure — Potential Paths for Reformby Ateev Mehrotra on 20/02/2021 at 12:30 pm
New England Journal of Medicine, Volume 384, Issue 8, Page 687-690, February 2021. <br/>
- Gum Hypertrophy from Cyclosporineby Bina S. Menon on 20/02/2021 at 12:30 pm
New England Journal of Medicine, Volume 384, Issue 8, Page 744-744, February 2021. <br/>
- Vaccinating Health Care Employees — Do They All Deserve Early Access?by Peter A. Ubel on 19/02/2021 at 5:00 am
New England Journal of Medicine, Ahead of Print. <br/>
